S. Dubrey et al., DOPPLER DETERMINED AORTIC ACCELERATION AFTER DIPYRIDAMOLE IN THE PREDICTION OF CORONARY-ARTERY DISEASE, International journal of cardiology, 51(1), 1995, pp. 5-14
Change in the acceleration of aortic blood flow with stress testing is
reported to reflect the presence of myocardial ischaemia. We studied
its clinical usefulness when compared with dipyridamole thallium scint
igraphy in 101 patients, of whom 64 had coronary angiography. Maximum
aortic acceleration increased after dipyridamole (P < 0.0001), althoug
h no correlation existed between the aortic acceleration and evidence
of thallium perfusion abnormalities. For the patients who had angiogra
phy, the increase in aortic acceleration was similar for those with no
significant coronary stenoses, single vessel or multi-vessel disease.
Compared with coronary angiography, Doppler measurement of maximum ao
rtic acceleration had a sensitivity of 92% and a specificity of 37% fo
r the detection of coronary artery disease. When patients with previou
s myocardial infarction or left ventricular dysfunction were excluded,
there was still no relationship between the maximum aortic accelerati
on and the presence of coronary artery disease. We conclude that chang
es in the acceleration of aortic blood flow after dipyridamole stressi
ng do not predict the presence or severity of coronary artery disease
as measured from perfusion defects at thallium scintigraphy or by coro
nary angiography. We have observed a wide variability of aortic maximu
m acceleration in the evaluation of myocardial ischaemia, which we fee
l introduces serious limitations to its use in routine clinical practi
ce.